Biblio
Export 1711 results:
Author [ Title
Filters: First Letter Of Last Name is C [Clear All Filters]
“Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 455-464, 2018.
, “Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 455-464, 2018.
, “Circulating miR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 455-464, 2018.
, “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
, “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
, “The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 557-565, 2017.
, “Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
, “Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.”, J Alzheimers Dis, vol. 80, no. 3, pp. 941-947, 2021.
, “Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.”, J Alzheimers Dis, vol. 80, no. 3, pp. 941-947, 2021.
, “Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea).”, J Alzheimers Dis, vol. 53, no. 2, pp. 463-73, 2016.
, “Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea).”, J Alzheimers Dis, vol. 53, no. 2, pp. 463-73, 2016.
, “Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea).”, J Alzheimers Dis, vol. 53, no. 2, pp. 463-73, 2016.
, “Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 411-23, 2016.
, “Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 411-23, 2016.
, “Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1417-1425, 2018.
, “Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave.”, J Alzheimers Dis, vol. 81, no. 2, pp. 679-690, 2021.
, “Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave.”, J Alzheimers Dis, vol. 81, no. 2, pp. 679-690, 2021.
, “Clinical Response to Donepezil in Mild and Moderate Dementia: Relationship to Drug Plasma Concentration and CYP2D6 and APOE Genetic Polymorphisms.”, J Alzheimers Dis, vol. 55, no. 2, pp. 539-549, 2017.
, “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.
, “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.
, “A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging.”, J Alzheimers Dis, vol. 71, no. 1, pp. 57-82, 2019.
, “Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.”, J Alzheimers Dis, vol. 64, no. s1, pp. S3-S22, 2018.
, “The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1659-1666, 2017.
, “The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1659-1666, 2017.
, “Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.”, J Alzheimers Dis, vol. 49, no. 1, pp. 121-7, 2016.
,